October 19, 2026 • 4:05pm EDT Solventum Announces FDA 510(k) Clearance for Combined Use of Restrata™ Matrix and Solventum™ V.A.C.® Therapy*
October 15, 2026 • 4:05pm EDT Solventum to Report Third Quarter Fiscal 2026 Earnings on November 5, 2026
September 2, 2026 • 4:05pm EDT Solventum to Participate in the 2026 Wells Fargo Healthcare Conference
Dentistry Today Oct. 20, 2026 Solventum Unveils Next-Generation Filtek Matrix Restorative System Read More